Investment
Features
FeesSafety
Academy
More
Pluang+

Researchers simulate a 50-qubit quantum computer using NVIDIA's JUPITER, setting a new benchmark in quantum computing.

Protocol Fundamentals
19 Oct 2026
Tokenpost
View Source
Bullish
Researchers simulate a 50-qubit quantum computer using NVIDIA's JUPITER, setting a new benchmark in quantum computing.

The Jülich Supercomputing Centre and NVIDIA used the JUPITER supercomputer to simulate a universal 50-qubit quantum computer, surpassing their previous 48-qubit record from 2019. This full-state simulation required 2,048 TiB of memory, achieved through advanced byte encoding and GPU-CPU memory sharing, enabling researchers to study quantum circuits without physical quantum hardware. The simulation offers a noise-free reference to test quantum circuits, important as real quantum processors face errors. NVIDIA also announced a related project simulating a 104-qubit fault-tolerance protocol, highlighting ongoing advances in quantum computing research.

The simulation of a 50-qubit quantum computer by NVIDIA and Jülich offers context for readers interested in cutting-edge technology. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 20, 2026 08:21 WIB: out of 50 priced major cryptocurrencies, 16 rose and 33 fell today. Notable movers include Basic Attention Token (BAT) at Rp3.444 with a 1-day change of +9.20% and a typical hold time on Pluang of 93 days, EOS (EOS.IO) at Rp12.649 with +8.13%, and Zilliqa (ZIL) at Rp39 with -5.70% and a typical hold time of 133 days.

More News

Anteris gets German clearance to expand global PARADIGM heart valve trial, boosting patient recruitment.

Anteris gets German clearance to expand global PARADIGM heart valve trial, boosting patient recruitment.

Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...

Market News
Bullish
2 hours ago
XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
4 hours ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
4 hours ago
Solana's non-vote transactions hit 8.92B in Q3 2026, up 104% from Q4 2025, setting new weekly and monthly records.

Solana's non-vote transactions hit 8.92B in Q3 2026, up 104% from Q4 2025, setting new weekly and monthly records.

Solana recorded 8.92 billion non-vote transactions from July to September 2026, marking a 104% increase compared to the fourth quarter of 2025. These transactions exclude validator votes and include activities like transfers, trading, and decentraliz...

Protocol Fundamentals
Bullish
4 hours ago
Jio Platforms' IPO anchor book oversubscribed 30x with $26.3B bids from top global investors

Jio Platforms' IPO anchor book oversubscribed 30x with $26.3B bids from top global investors

Jio Platforms, backed by Meta and Google, has seen its IPO anchor book oversubscribed over 30 times, attracting $26.3 billion in bids for an $854 million portion. The company aims to raise up to $3.2 billion in India's largest-ever IPO by rupee value...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App